RAC 2.92% $1.94 race oncology ltd

Ann: Trading Halt, page-124

  1. 1,121 Posts.
    lightbulb Created with Sketch. 301
    I’m firming on an addition of some kind. scenarios as my small brain sees them.

    departures:
    - Heeney: who cares. Not price sensitive.
    - Sharp: ditto above.
    - DCB: unfathomable
    - Tilllet: super unlikely. Too exposed with his investment.
    - Lynch: Possible. More likely he moves to chair.
    - Cullity. Maybe. Wouldn’t be surprising if he left. He might also just be content to hand over the reins as chair to someone else and stick on the journey as a director. Suppose it depends on his outlook for a transaction. One thing is for sure, we will over analyse his decision.

    reshuffle: without departure or additions, a reshuffle is not price sensitive. IMO.

    additions:
    To be price sensitive, it has to involve a partnership, sale of shares, new equity, or something wildly left field (e.g. fraud… Tillet fudged the cardio results in some kind of scientific ponzi).

    my best (hopeful) guess is an industry partner or collaborator getting a decent stake with shares from Cullity and maybe Tillet at a decent premium to recent share price - above $3.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.94
Change
0.055(2.92%)
Mkt cap ! $330.4M
Open High Low Value Volume
$1.89 $1.96 $1.85 $333.0K 174.5K

Buyers (Bids)

No. Vol. Price($)
1 3105 $1.94
 

Sellers (Offers)

Price($) Vol. No.
$1.95 7574 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.